Compare LGND & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LGND | ACHC |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | United States |
| Employees | 68 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | N/A | 2011 |
| Metric | LGND | ACHC |
|---|---|---|
| Price | $299.86 | $34.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 15 |
| Target Price | ★ $256.29 | $22.67 |
| AVG Volume (30 Days) | 354.1K | ★ 3.2M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $3,312,769,000.00 |
| Revenue This Year | $1.25 | $5.08 |
| Revenue Next Year | $19.41 | $5.98 |
| P/E Ratio | ★ $76.27 | $680.20 |
| Revenue Growth | N/A | ★ 5.04 |
| 52 Week Low | $131.67 | $11.43 |
| 52 Week High | $326.63 | $35.83 |
| Indicator | LGND | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 67.18 |
| Support Level | $290.20 | $22.52 |
| Resistance Level | $326.63 | N/A |
| Average True Range (ATR) | 10.96 | 1.50 |
| MACD | -3.74 | 0.12 |
| Stochastic Oscillator | 24.94 | 80.02 |
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.